Litcius/Paper detail

Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry)

Ovidio De Filippo, Jeehoon Kang, Francesco Bruno, Jung‐Kyu Han, Andrea Saglietto, Han‐Mo Yang, Giuseppe Patti, Kyung Woo Park, Radosław Parma, Hyo‐Soo Kim, Leonardo De Luca, Hyeon‐Cheol Gwon, Mario Iannaccone, Woo Jung Chun, Grzegorz Smołka, Seung‐Ho Hur, Enrico Cerrato, Seung Hwan Han, Carlo Di Mario, Young Bin Song, Javier Escaned, Ki Hong Choi, Gérard Helft, Joon‐Hyung Doh, Alessandra Truffa Giachet, Soon Jun Hong, Saverio Muscoli, Chang‐Wook Nam, Guglielmo Gallone, Davide Capodanno, Daniela Trabattoni, Yoichi Imori, Veronica Dusi, Bernardo Cortese, Antonio Montefusco, Federico Conrotto, Iacopo Colonnelli, Imad Sheiban, Gaetano Maria De Ferrari, Bon‐Kwon Koo, Fabrizio D’Ascenzo

2021The American Journal of Cardiology16 citationsDOIOpen Access PDF

Topics & Concepts

MaceMedicinePercutaneous coronary interventionCardiologyInternal medicineAcute coronary syndromeConventional PCIMyocardial infarctionRestenosisClinical endpointCohortCoronary artery diseaseStentClinical trialAntiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and DiagnosticsAtrial Fibrillation Management and Outcomes